ELTROMBOPAG VIATRIS 50 mg, film-coated tablet 14 tablets
Active ingredients: Eltrombopag, Eltrombopag olamine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ELTROMBOPAG VIATRIS 50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 14 comprimé(s)
- Marketing authorisation holder
- VIATRIS (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60724264CIP73030685CIP133400930306857Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ELTROMBOPAG OLAMINEcomprimé | — | SA |
| ELTROMBOPAGcomprimé | 50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.